Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128767) titled 'A Study on the Efficacy and Safety of Zuberitamab Injection Combined with Glucocorticoids as First-Line Therapy for Warm Antibody Autoimmune Hemolytic Anemia' on July 25.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Zhejiang University School of Medicine
Condition:
warm antibody autoimmune hemolytic anemia
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Zuberitamab combined with glucocorticoid group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...